Abimmune Biopharma CEO Flora Fan spoke with Proactive at the Biotech Showcase 2020 in San Francisco. The privately-held, San Diego-based company is developing multi-targeting immuno-oncology protein drugs. According to the company, its lead candidate will reach Investigational New Drug enablement within one year.
Abimmune Biopharma aiming to 'significantly elevate' the standard of cancer care
Abimmune Biopharma CEO Flora Fan spoke with Proactive at the Biotech Showcase 2020 in San Francisco. The privately-held, San Diego-based company is developing multi-targeting immuno-oncology protein drugs. According to the company, its lead candidate will reach Investigational New Drug enablement within one year.
0 Comments